Organization
University of Colorado Denver Anschutz Medical Center
23 abstracts
Abstract
Mental healthcare utilization and psychosocial outcomes among patients with recently diagnosed cancer: A National Health Interview Survey report.Org: University of Colorado Denver Anschutz Medical Center,
Abstract
Smoking and pathogenic germline variants in patients with lung cancer.Org: Invitae Corporation, Invitae, University of Colorado Cancer Center, University of Colorado Denver Anschutz Medical Center,
Abstract
Implementing personalized lung cancer care with spatial profiling, patient derived organoids, and rationally designed drug testing.Org: University of Colorado Anschutz Medical Campus, University of Colorado Cancer Center, University of Colorado School of Medicine, Veterans Affairs Medical Center, University of Colorado Denver Anschutz Medical Center,
Abstract
Strategies to increase accrual of underrepresented populations in Alliance NCTN trials.Org: The Ohio State University - James Cancer Hospital, Columbus, OH, Alliance NCTN Foundation, Chicago, IL, University of Colorado Denver Anschutz Medical Center,
Abstract
A phase 1, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of PF-07799933 (ARRY-440) as a single agent and in combination therapy in participants 16 years and older with advanced solid tumors with BRAF alterations.Org: Sarah Cannon Research Institute/Tennessee Oncology, Tennessee Oncology, PLLC, Henry Ford Cancer Institute, Detroit, MI, University of Colorado Denver Anschutz Medical Center, Dana-Farber Cancer Institute,
Abstract
Safety and clinical activity of oleclumab (O) ± durvalumab (D) + chemotherapy (CT) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): A phase 1b/2 randomized study.Org: Fred Hutchinson Cancer Center/Division of Hematology and Oncology, University of Virginia Comprehensive Cancer Center, University of Michigan Health System Comprehensive Cancer Center, Hospital Universitari Vall d'Hebron Research Institute, Roswell Park Cancer Institute,
Abstract
Incorporating long non-coding RNA (lncRNA) into genome-wide biomarker screening for prognostic gene signatures of immunotherapy outcomes.Org: H. Lee Moffitt Cancer Center and Research Institute, Ohio State University Comprehensive Cancer Center, University of Virginia, Charlottesville, VA, USA, University of Colorado Denver Anschutz Medical Center, University of Southern California - Health Sciences Campus,
Abstract
Genetic heterogeneity between paired primary and metastatic solid tumors and implications for neoantigen-based personalized cancer vaccines.Org: H. Lee Moffitt Cancer Center and Research Institute, M2GEN, Huntsman Cancer Institute at the University of Utah, Stephenson Cancer Center, Ohio State University Wexner Medical Center,
Abstract
A phase II, randomized, double-blind study of the use of rucaparib vs placebo maintenance therapy in metastatic and recurrent endometrial cancer.Org: University of Colorado Cancer Center, The University of Pennsylvania, University of Pittsburgh, Pittsburgh, PA, University of Pennsylvania, University of Colorado Denver Anschutz Medical Center,
Abstract
Characteristics of long-term survivors with EGFR mutant (EGFRm) metastatic non-small cell lung cancer (mNSCLC).Org: Genentech, Princess Margaret Cancer Centre, Norris Comprehensive Cancer Center, Laura and Isaac Perlmutter Cancer Center, Lombardi Comprehensive Cancer Center,
Abstract
Eliminating barriers to uptake of germline genetic testing for patients with advanced cancer: The GTAC study.Org: University of Vermont Larner College of Medicine, University of Vermont Cancer Center, Invitae, University of Colorado Denver Anschutz Medical Center,
Abstract
Brentuximab vedotin + AVD for newly diagnosed classic Hodgkin lymphoma (cHL): Incidence and management of peripheral neuropathy in a multi-institution cohort.Org: Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, University of Colorado Denver Anschutz Medical Center, Aurora, CO,
Abstract
Phase I study of the mutant IDH1 inhibitor ivosidenib: Long-term safety and clinical activity in patients with conventional chondrosarcoma.Org: Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College University, Massachusetts General Hospital, Sarah Cannon Research Institute/Tennessee Oncology, Children's Hospital Colorado, Aurora, CO,
Abstract
Leadership knowledge and beliefs regarding diversity, equity, and inclusion at SWOG Cancer Research Network.Org: O'Neal Comprehensive Cancer Center at UAB, Southwest Oncology Group Statistical Center, Loma Linda University Department of Radiation Technology, University of Colorado Denver Anschutz Medical Center, SWOG Cancer Research Network,
Abstract
Evaluating genetic screening/counseling for patients diagnosed with prostate cancer who meet hereditary risk assessment based on NCCN Guidelines.Org: Northeast Georgia Medical Center, University of Colorado Denver Anschutz Medical Center,
Abstract
Using cell-free DNA to predict response to immunotherapy in non-small cell lung cancer pre- and post-treatment.Org: University of Colorado Denver Anschutz Medical Center, University of Colorado Cancer Center, University of Colorado Denver | Anschutz Medical Campus, Division of Medical Oncology, University of Colorado, Drammen Hospital. Dept. of Oncology.,
Abstract
Identifying associations between race and gender in the incidence and mortality of patients with multiple myeloma.Org: Northeast Georgia Medical Center, University of Colorado Denver Anschutz Medical Center,
Abstract
Effect of durable hematocrit control and minimal thrombotic risk in real-world polycythemia vera patients treated with ruxolitinib.Org: Levine Cancer Institute Atrium Health, Levine Cancer Institute, Department of Hematologic Malignancies and Blood Disorders, Yale School of Medicine, Yale University,
Abstract
Diversity, equity, and inclusion (DEI) champions: Lessons learned and implications for future programming to support cancer clinical trials.Org: Southwest Oncology Group Statistical Center, University of Colorado Denver Anschutz Medical Center, University of Alabama Medical Center, Loma Linda University Department of Radiation Technology, Loyola University Medical Center,
Abstract
Pilot randomized trial of a telehealth intervention for women with advanced ovarian cancer and PARP inhibitor-related fatigue.Org: Dana-Farber Cancer Institute, University of Colorado Anschutz Medical Campus, Harvard Medical School, University of Colorado Boulder, University of Pennsylvania,
Abstract
Clinical trial knowledge among cancer survivors in the United States: The role of health information technology.Org: Northeast Georgia Medical Center, MedStar Union Memorial Hospital, MD Anderson Cancer Center, Massachusetts General Hospital, Ministry of Health Lagos,
Abstract
ABATACEPT SC VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RA: ONE YEAR RESULTS FROM THE AMPLE STUDY Org: Bristol-Myers Squibb, University of Colorado Denver Anschutz Medical Center, University of Texas Southwestern Medical Center, Brigham and Women's Hospital/Massachusetts General Hospital, Arthritis Center of Nebraska,
Abstract
ABATACEPT PROVIDES AN INCREASING MAGNITUDE OF RESPONSE OVER TIME IN MEASURES OF RHEUMATOID ARTHRITIS DISEASE ACTIVITY: RESULTS FROM THE ATTEST TRIALOrg: University of Colorado Denver Anschutz Medical Center, Bristol-Myers Squibb, Hopital Cochin, Descartes University,